UPDATE: To Watch the Replay of Kyle’s Option Rocket Webinar
>>> Click Here and Register <<<
You’ll receive your replay link in a few minutes.
I already have thousands of people attending and our servers can only hold so many, so be sure to secure your seat right now!
Really nice day out there again! The best trade of the day ended up being one of our quick moving opportunities. VTVT was about $5,000 in profits!
I also picked up a position again in IDRA. The data from their abstract at ASCOlooked promising, and the company also has another data release coming in June. A two for one special!
I took a started position in GBT as well, right from our watch list.
So was quite the busy day.
Just a reminder, charts and targets are updated every Monday morning!
—– Related —–
FREE DOWNLOAD
Kyle Dennis FREE EBOOK “The $2.9 Million Biotech Trader Playbook”
This book has helped thousands of other traders learn the basics of biotech, and how to easily spot winning trades.
Whether you are new trader or a 30-year veteran, this book will help you find stocks that are primed to make parabolic moves. These strategies are Kyle’s secret weapons that have help him net over $3 Million in profits…and they are all yours for free.
This is normally $97.00, but it’s yours FREE!
New Catalyst Swing names (1 – 4 week holds) I am watching…
Idera Pharmaceuticals (IDRA)
Catalyst Dates: Phase 2 data due out June 4th and another Phase 2 data readout in June
Buy Zone: $1.75 to $1.95
Profit Zone: $2.20 or higher
Stop Zone: $1.70 or below
Catalyst Swing names (1 – 4 week holds) I am watching…
Aquinox Pharmaceuticals (AQXP)
Catalyst Dates: Phase 3 data due out in the third quarter
Buy Zone: $12.50 to $13.50
Profit Zone: $16.00 or higher
Stop Zone: $11.50 or below
Bellerophon Therapeutics (BLPH)
Catalyst Dates: Interim Phase 3 data release in the middle of 2018 (likely late June or July)
Buy Zone: $2.20 to $2.40
Profit Zone: $2.75 or higher
Stop Zone: $2.10 or below
Durect Corporation (DRRX)
Catalyst Dates: Advisory Committee meeting on June 26th, FDA Approval dates on July 28th and August 7th.
Buy Zone: $1.75 to $2.00
Profit Zone: $2.40 or higher
Stop Zone: $1.65 or below
Array BioPharma (ARRY)
Catalyst Dates: Phase 3 data due out June 20-23. FDA approval date of June 30 as well.
Buy Zone: $14.50 to $15.50
Profit Zone: $18.00 or higher
Stop Zone: $14.00 or below
Global Blood Therapeutics (GBT)
Catalyst Dates: Phase 3 data likely due out in June. Officially in the “first half”
Buy Zone: $48.00 to $50.00
Profit Zone: $57.00 or higher
Stop Zone: $45.00 or below
Pluristem Therapeutics (PSTI)
Catalyst Dates: Phase 2 data due out to be published in June.
Buy Zone: $1.30 to $1.45
Profit Zone: $1.80 or higher
Stop Zone: $1.20 or below
Marinus Pharmaceuticals (MRNS)
Catalyst Dates: Phase 2 data due out in the third quarter. Two other Phase 2 datas due out in the fourth quarter.
Buy Zone: $4.25 to $4.75
Profit Zone: $6.00 or higher
Stop Zone: $4.00 or below
Cytokinetics Incorporated (CYTK)
Catalyst Dates: Phase 2 data due out June 16
Buy Zone: $8.50 to $9.00
Profit Zone: $10.00 or higher
Stop Zone: $7.40 or below
Zogenix (ZGNX)
Catalyst Dates: Phase 3 data due late second quarter (likely June)
Buy Zone: $39.50 to $40.50
Profit Zone: $45.00 or higher
Stop Zone: $37.50 or below
Catalyst Biosciences (CBIO)
Catalyst Dates: Phase 2 data in July
Buy Zone: $26.50 to $28.50
Profit Zone: $33.00 or higher
Stop Zone: $25.00 or below
Pain Therapeutics (PTIE)
Catalyst Dates: Advisory Committee Meeting June 26th and FDA approval date of August 7th
Buy Zone: $7.50 to $8.25
Profit Zone: $9.50 or higher
Stop Zone: $7.00 or below
[Ed.note: Kyle Dennis runs BiotechBreakouts.com. He is an event-based trader, who prefers low-priced and small-cap biotech stocks.